Substandard and falsified medicines can find their way into the supply chain in many ways: through mislabelling, human error, intentional adulteration by manufacturers or suppliers to achieve higher profits, or other more complex ways.
The latest proof comes from the World Health Organization’s (WHO)’s recent Medical Product Alert about four substandard products identified in The Gambia. The WHO reported that these products are potentially linked to the deaths of 66 children.
Given the complex pharmaceutical supply chain, there is a clear need for greater focus on securing the global supply chain. All the actors involved in the medicines supply chain have a role to play, including you!
Join Fight the Fakes Week and raise awareness about the urgent need to secure the global medicines supply chain to keep patients safe from substandard and falsified medicines.